Spontaneous Extrapleural Hematoma: A Rare Cause of Acute Chest Pain in Hemodialysis Patients

A medical case report published in the journal Cureus has highlighted a rare cause of acute chest pain in patients undergoing hemodialysis: spontaneous extrapleural hematoma. This condition involves the accumulation of blood in the extrapleural space, the area between the parietal pleura and the endothoracic fascia, occurring without a history of trauma.

The report details the presentation of a patient with end-stage renal disease (ESRD) who was receiving maintenance hemodialysis and anticoagulation therapy. The patient presented with acute chest pain, a symptom that frequently mimics more common and life-threatening conditions such as myocardial infarction or pulmonary embolism.

Diagnostic Challenges and Findings

Diagnosis of spontaneous extrapleural hematoma is often difficult because its clinical presentation is non-specific. In the case described in Cureus, the patient’s acute chest pain necessitated urgent investigation to rule out cardiovascular or pulmonary emergencies.

The diagnosis was confirmed through computed tomography (CT) imaging of the chest. The scan revealed a collection of blood within the extrapleural space, distinguishing it from a pleural effusion, which occurs within the pleural cavity itself. The distinction is critical for determining the appropriate management strategy.

Unlike pleural effusions, which are relatively common in patients with renal failure due to fluid overload or inflammation, extrapleural hematomas are exceedingly rare and typically associated with specific risk factors that predispose a patient to bleeding.

The Role of Anticoagulation and Uremia

The report identifies two primary contributing factors to the development of the hematoma: the use of anticoagulants during hemodialysis and the underlying physiological state of the patient.

Anticoagulation therapy, such as the use of heparin, is standard during hemodialysis to prevent the clotting of blood within the dialysis machine’s circuit. However, this systemic anticoagulation increases the risk of spontaneous bleeding in various tissues.

patients with ESRD often suffer from uremic platelet dysfunction. Uremia, the buildup of waste products in the blood due to kidney failure, impairs the ability of platelets to aggregate and form clots. This combination of pharmacological anticoagulation and biological platelet dysfunction creates a high-risk environment for spontaneous hemorrhagic events.

Management and Clinical Implications

Management of spontaneous extrapleural hematoma in this context generally focuses on stabilization and the correction of coagulopathy. For the patient in the report, the focus was on managing the bleeding risk while maintaining the necessary dialysis schedule.

Clinical management typically involves:

• Careful monitoring of hemodynamic stability.
• Adjustment or temporary cessation of anticoagulation therapy.
• Supportive care to allow the hematoma to resorb spontaneously.

The Cureus report emphasizes that while these hematomas can be alarming on imaging, they often resolve with conservative management, provided that the underlying cause of the bleeding is addressed and the patient remains stable.

The primary clinical takeaway for healthcare providers is the importance of including spontaneous extrapleural hematoma in the differential diagnosis for acute chest pain in hemodialysis patients, especially those with known coagulopathies or those receiving potent anticoagulants.

By recognizing this rare possibility, clinicians can avoid unnecessary invasive procedures and implement the correct conservative management strategies, potentially reducing complications for patients already facing the complexities of end-stage renal disease.